Health Condition 1: C500- Malignant neoplasm of nipple and areola
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) American society of Anesthesiology 1 and 2 2) patient more than 18 year 3)weight more than 35 kg
Exclusion criteria
Exclusion criteria: 1) The patient refused to undergo the study procedure. 2) The patient has a history of allergies to drugs or drug components used in the study. 3) The patient has a history of neurological deficits. 4) Patients with opioid dependence or addiction are excluded. 5) Patients with American Society of Anesthesiologists physical status classification III or IV are excluded. 6) Patients who took analgesics within 24 hours prior to induction are excluded. 7) Patients with infections at the site of injection are excluded. 8) Patients with inherited or acquired coagulopathies are excluded. 9) Patients on systemic anticoagulation therapy are excluded. 10) Patients with a BMI over 40 are excluded. 11) Patients with psychiatric disorders are excluded.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To evaluate and compare Total TRAMADOL consumption in the first 24 hours between two groups of patients who are undergoing breast malignancy surgeries under general anesthesia (GA) with either Erector Spinae Plane block or Modified Pectoral nerve block. Timepoint: AFTER 24 hours | — |
Secondary
| Measure | Time frame |
|---|---|
| To calculate VAS score To check additional analgesia requirementTimepoint: To check any side effects of procedure | — |
Countries
India
Contacts
Mahatma Gandhi Institute of Medical Sciences, Sevagram